Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07223437 · ClinicalTrials.gov registry record · NA
REVASC-PAD: REstricted VASCular Exercise for Peripheral Arterial Disease - A Feasibility Study at University of Tennessee Medical Center
A NA study, sponsored by University of Tennessee Graduate School of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 81
- Enrollment target
NCT07223437 is a NA study that is actively recruiting participants, run by University of Tennessee Graduate School of Medicine. The registered enrollment target is 81 participants.
The verdict
NCT07223437, a NA study, is actively recruiting participants, sponsored by University of Tennessee Graduate School of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of Blood Flow Restriction (BFR) training on walking function, health-related quality of life, and safety among adults with Peripheral Arterial Disease (PAD). The main aims of the study are: 1. Evaluate change in walking function among patients with PAD undergoing BFR training. The investigators will assess change in Six-Minute Walk Test (6MWT) distance from baseline to post-intervention and 3-month follow-up to compare functional improvements between the BFR group and the two control groups 2. Assess changes in health-related quality of life among patients with PAD undergoing BFR training. The investigators will use the EuroQol 5-Dimension 5-Level (EQ-5D-5L) scale to evaluate quality-of-life changes from baseline to post-intervention and 3-month follow-up across all study arms 3. Evaluate the safety and feasibility of a supervised BFR training program for patients with PAD. The investigators will compare adverse event (AE) and serious adverse event (SAE) rates across study arms, while also monitoring sessional ratings of perceived exertion (RPE), dyspnea, and claudication pain as indicators of symptom response and exercise tolerance. Feasibility will be assessed through enrollment success, intervention adherence, and retention rates across groups
Interventions
- BEHAVIORAL Blood Flow Restriction Cuff System
- BEHAVIORAL Low-load Resistance Training
- BEHAVIORAL High-load Resistance Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2026-04-27 |
| Est. Completion | 2027-04-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07223437
The ClinicalTrials.gov registry entry for NCT07223437 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Tennessee Graduate School of Medicine, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Blood Flow Restriction Cuff System is the first listed.
NCT07223437 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07223437 about?
NCT07223437 is a clinical study titled "REVASC-PAD: REstricted VASCular Exercise for Peripheral Arterial Disease - A Feasibility Study at University of Tennessee Medical Center". The purpose of this study is to evaluate the effects of Blood Flow Restriction (BFR) training on walking function, health-related quality of life, and safety among adults with Peripheral Arterial Disease (PAD). The main aims of the study are: 1. Evaluate change in walking function among patients w...
What is the current status of trial NCT07223437?
This trial is currently recruiting. It is a NA study. The enrollment target is 81 participants. The study started on 2026-04-27. Estimated completion is 2027-04-27.
What interventions are being tested in trial NCT07223437?
The interventions under investigation include: Blood Flow Restriction Cuff System (BEHAVIORAL), Low-load Resistance Training (BEHAVIORAL), High-load Resistance Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT07223437?
This trial is sponsored by University of Tennessee Graduate School of Medicine, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.